Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Depsipeptides × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell, Cutaneous 3 Mycosis Fungoides 2 Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic, T-Cell 1 Inflammatory Breast Neoplasms 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Breast Neoplasms, Male 1

Interventions

lutetium Lu 177 dotatate 21 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Everolimus 8 Specimen Handling 7 cabozantinib 6 Nivolumab 6 surufatinib 5 lenvatinib 5 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 olaparib 4 amino-acid, glucose, and electrolyte solution 4 Octreotide 4 lanreotide 3 gallium Ga 68 dotatate 3 atezolizumab 3 Temozolomide 3 Lutetium-177 3 Ipilimumab 3 Injections 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 tislelizumab 2 fludarabine phosphate 2 fludarabine 2 avelumab 2 X-Rays 2 Surveys and Questionnaires 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡